This federal contract award is for Doxepin HCL 3 mg tablets in 30-count packages, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $3,287.54 firm fixed price delivery order has a completion date of February 26, 2024. Amerisourcebergen Drug Corp is the prime contractor, without any set-aside designation, and has received numerous previous awards from DLA Troop Support Medical to provide pharmaceuticals and medical supplies for military treatment programs. The company also holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to deliver a comprehensive range of medications and healthcare materials to DLA Troop Support Medical facilities supporting the Department of Defense.
Generated 5/24/24, 9:52 AM